Osaic Holdings’s Contineum Therapeutics CTNM Stock Holding History

Osaic Holdings’s Portfolio CTNM Stock Details CTNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$197	Buy	12 +6	+100%	+$79	﹤0.01%	7783
2026 Q1	$78	Buy	+6	New	+$80	﹤0.01%	7650
2025 Q3	–	Sell	-10	Closed	-$70	–	8024
2025 Q2	$70	Buy	+10	New	+$43	﹤0.01%	7592

Other funds holding CTNM

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Osaic Holdings's CTNM Position: Q2 2026 in Review

Osaic Holdings increased its Contineum Therapeutics (CTNM) stake by 100% in Q2 2026, buying an estimated $79 and bringing the position to 12 shares worth $197. The position accounts for ﹤0.01% of the portfolio, ranked #7783.

Osaic Holdings first reported a position in CTNM in Q2 2025 and has held it in 3 quarters since. 102 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

Osaic Holdings held 12 shares of Contineum Therapeutics worth $197 as of Q2 2026.
Osaic Holdings bought 6 Contineum Therapeutics shares in Q2 2026, an estimated $79.
Contineum Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7783 holding.
Osaic Holdings first reported a position in Contineum Therapeutics in Q2 2025 and has held it in 3 quarters since.
102 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.